Document detail
ID

doi:10.1007/s10072-022-06505-x...

Author
Poletti, Barbara Aiello, Edoardo Nicolò Solca, Federica Torre, Silvia Carelli, Laura Ferrucci, Roberta Verde, Federico Ticozzi, Nicola Silani, Vincenzo
Langue
en
Editor

Springer

Category

Medicine & Public Health

Year

2022

listing date

11/30/2022

Keywords
edinburgh cognitive and behavioura... amyotrophic lateral sclerosis frontotemporal degeneration behavioural symptom psychometrics ecas fbi sc ecas-ci nos
Metrics

Abstract

Background This study aimed at providing diagnostic properties and normative cut-offs for the Italian ECAS Carer Interview (ECAS-CI).

Materials N  = 292 non-demented ALS patients and N  = 107 healthy controls (HCs) underwent the ECAS-CI and the Frontal Behavioural Inventory (FBI).

Two ECAS-CI measures were addressed: (1) the number of symptoms (NoS; range  = 0–13) and (2) that of individual symptom clusters (SC; range  = 0–6).

Diagnostics were explored against an FBI score ≥ than the 95th percentile of the patients’ distribution.

Results Both the NoS and SC discriminated patient from HCs.

High accuracy, sensitivity, and specificity were detected for both the NoS and SC; however, at variance with SC, the NoS showed better post-test features and did not overestimate the occurrence of behavioural changes.

The ECAS-CI converged with the FBI and diverged from the cognitive section of the ECAS.

Discussion The ECAS-CI is a suitable screener for behavioural changes in ALS patients, with the NoS being its best outcome measure (cut-off: ≥ 3).

Poletti, Barbara,Aiello, Edoardo Nicolò,Solca, Federica,Torre, Silvia,Carelli, Laura,Ferrucci, Roberta,Verde, Federico,Ticozzi, Nicola,Silani, Vincenzo, 2022, Diagnostic properties of the Italian ECAS Carer Interview (ECAS-CI), Springer

Document

Open

Share

Source

Articles recommended by ES/IODE AI

High-Frequency Repetitive Magnetic Stimulation at the Sacrum Alleviates Chronic Constipation in Parkinson’s Patients
magnetic stimulation parkinson’s significant patients scale sacrum pd hf-rms chronic constipation scores
The mechanism of PFK-1 in the occurrence and development of bladder cancer by regulating ZEB1 lactylation
bladder cancer pfk-1 zeb1 lactylation glycolysis inhibits lactate glucose bc pfk-1 cancer lactylation cells bladder